Immutep

+$0.02 (+0.74%) Today
$0.00 (0.00%) As of 8:25 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immutep and other ETFs, options, and stocks.

About IMMP

Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma.

CEO
Marc Voigt
Employees
—
Headquarters
Sydney, New South Wales (NSW)
Founded
1987

IMMP Key Statistics

Market cap
242.27M
Price-Earnings ratio
—
Dividend yield
—
Average volume
75.34K
High today
$2.74
Low today
$2.66
Open price
$2.68
Volume
46.89K
52 Week high
$5.44
52 Week low
$2.02

IMMP News

Simply Wall StMay 19

Is Immutep Weighed On By Its Debt Load? - Simply Wall St

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to consider debt, when you think about how ris

IMMP Earnings

Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Jul 30, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure